Skip to content

The Efficacy of Transcutaneous Electrical Acupoint Stimulation Combined with Ear Copper Needle Scraping in the Treatment of Sudden Sensorineural Hearing Loss accompanied by Tinnitus

The Effect of Transcutaneous Electrical Acupoint Stimulation Combined with Ear Copper Needle Scraping on Recovery Quality in Patients with Sudden Sensorineural Hearing Loss accompanied by Tinnitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002155
Enrollment
Unknown
Registered
2025-11-08
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden onset sensorineural deafness accompanied by tinnitus

Interventions

experimental group:Transcutaneous electrical acupoint stimulation combined with ear copper needle scraping
control group:Conventional drug therapy

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the relevant diagnostic criteria in the 2015 Guidelines for the Diagnosis and Treatment of Sudden Hearing Loss; 2.Tinnitus symptoms are present during the onset of the disease; 3.Age 18~65 years old onset to medical treatment = 2 weeks; 4.Those who are conscious and have no mental illness can correctly understand and cooperate with treatment; 5.The patient signs an informed consent form and agrees to participate in the clinical trial.

Exclusion criteria

Exclusion criteria: 1.The presence of severe diseases of important organs, such as the heart, liver, or kidneys, or malignant tumors; 2.The existence of skin lesions on the ear or hand; 3.Being allergic to the drugs used in this trial; 4.Contraindications for TEAS, including the presence of rashes or local infections in the acupoint-stimulated skin area, implanted pacemakers or defibrillators, or skin allergy or itching caused by electrode patches; 5.The receipt of hormone therapy or acupuncture treatment in the past month; 6.Suspected or confirmed history of alcohol or drug abuse; 7.The existence of a pregnancy or breastfeeding; 8.Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Pure-tone audiometry;

Secondary

MeasureTime frame
tinnitus evaluation questionnaire;tinnitus handicap inventory;the Medical Outcomes Study 36-Item Short-Form Health Survey;

Countries

China

Contacts

Public ContactZhang.Biaoxin

The First Affiliated Hospital of Anhui Medical University

532611328@qq.com18325596005

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026